Sayenko Kharenko enjoys a global reputation as a leading Ukrainian law firm with an internationally oriented full-service practice. The firm specialises in complex cross-border and local matters and regularly handles the largest and most challenging projects involving Ukraine.
The firm has introduced many new products in Ukraine, especially in finance and capital markets, and has significantly contributed to the development of many markets and industries. Its clients especially value its practical and innovative approach and its ability to deeply understand and help achieve their strategic and business goals.
This has helped the firm become the preferred legal counsel for many of the largest multinational corporations, banks and other financial institutions, including Fortune 500 companies, industrial groups, international public organisations, and individual business owners.
The firm’s reputation as Ukraine’s leading firm in antitrust, corporate, GR, finance, intellectual property, international arbitration, international trade, labour, litigation, mergers and acquisitions, restructuring, real estate, securities and tax laws is confirmed by its high position in league tables, top rankings in the legal directories as well as international and local awards for its work.
The key facts about biosimilars and biologics in Ukraine. Prepared in association with Sayenko Kharenko, a leading law firm in Ukraine, this is an extract from The Pharma Legal Handbook: Ukraine, available to purchase here for GBP 99. 1. Are biosimilar medicines considered the same as generic medicines in your country? No, in Ukraine, biosimilar medicines are not considered the same as generic medicines. According to the Order of the Ministry of Health of Ukraine “On Approval of the Procedure to Examining Registration…
Want to know more about localization in Ukraine? Prepared in association with Sayenko Kharenko, a leading law firm in Ukraine, this is an extract from The Pharma Legal Handbook: Ukraine, available to purchase here for GBP 99. 1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? No, there are no rules or regulations requiring localisation with respect to medicinal products. 2. Have there been any…
An intro to the legal situation for orphan drugs and rare diseases in Ukraine. Prepared in association with Sayenko Kharenko, a leading law firm in Ukraine, this is an extract from The Pharma Legal Handbook: Ukraine, available to purchase here for GBP 99. 1. What is the definition of Rare Diseases in your country? Art. 3 of the Law of Ukraine “Fundamentals of the Legislation of Ukraine on Healthcare” (“Legislature on healthcare”)1 defines rare (orphan) disease as a disease that threatens human life…